Published January 13, 2015
| Version v1
Patent
Open
Adjuvants and methods of use
- 1. Scripps Research Institute
- 2. University of Chicago
- 3. Brigham Young University
Contributors
Description
Compositions comprising NKT cell agonist compounds and a physiologically acceptable vehicle are provided. Methods of stimulating an NKT cell and enhancing an immune response are also disclosed. Further provided are vaccine preparations comprising NKT cell agonist compounds.
Files
US8932594.pdf
Files
(1.1 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:f966b718e16c7ad60a3d30db64a8b933
|
1.1 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 85042810 A
- Patent number
- US 8932594 B2
- Other
- oai:uchicago.tind.io:9529
Dates
- Patent filed
-
2010-08-04